Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGroupe Francophone des Myelodysplasies
About this trial
The Registry MDS is an ongoing, observational study that has collected longitudinal data on diagnostics, demographics, clinical parameters, and health Care Interventions (HCI) from patients with MDS and therapy-related acute myeloid leukemia
Eligibility criteria
Qualifiers
Male or female
Age > 18 years
Patients with myelodysplastic syndrome and therapy-related acute myeloid leukemia
Able and willing to provide written informed consent
Disqualifiers
Age <18 years
Patient is unwilling or unable to give consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov